高清福利片

false

/content/dam/corporate/images/medicine-and-health/research/research-centres/the-arena-study-hero-image.jpeg

50%

The ARENA project

The Australasian Registry of ECGs of National Athletes
  • /medicine-health/industry-and-community/industry-partnerships/partnership-enquiries.html Partner with us
  • /medicine-health/industry-and-community/support-us.html Support us

m-hero--style-3

1280.1280.jpeg 1280w, 220.126.2x.jpeg 440w, 800.457.2x.jpeg 1600w, 1440.823.2x.jpeg 2880w, 2000.1330.2x.jpeg 4000w, 440.251.2x.jpeg 880w

false

The ARENA project is a long-term international data repository which aims to improve our understanding of ECG interpretation cardiac diagnoses, and the rates of major cardiovascular outcomes in screened athletes.听

50

automatic

Link

About us

The Australasian Registry of Electrocardiograms in National Athletes (ARENA) collects and centralises cardiac screening data from sporting organisations across Australasia. It is led by researchers at the University of Sydney, in collaboration with other national and international experts, and hosted by the听听(SAHMRI) Registry Centre. The ARENA study was launched in 2023, initially in Australia, with New Zealand to follow.

Sudden cardiac death (SCD) in athletes is a rare but tragic event. Cardiac screening of elite athletes for conditions associated with SCD is now widely recommended by leading bodies. Screening generally includes a personal and family history and a physical examination, together with a resting 12-lead electrocardiogram (ECG).

All elite sports in Australia and New Zealand conducting cardiac screening of athletes (including ECG) are eligible to participate. ARENA works closely with participating sporting organisations that can use this registry to improve the quality of their cardiac screening programs and provide better cardiac care for young athletes.

ARENA is endorsed by the Australasian College of Sport & Exercise Physicians and Sports Medicine Australia.

Registry information

The ARENA project aims to provide long-term international data to improve our understanding of:

  • the rate of diagnoses of conditions associated with SCD in screened athletes;
  • the role of different groups (e.g. athletes of various ages and sexes) in terms of accurate athlete ECG interpretation;
  • the bounds of normal cardiac adaptations to exercise across athletes from different Australasian sports to provide relevant benchmarks for normal athlete ECG features and accurate interpretation;
  • and major cardiovascular outcomes of screened athletes

Full details are available in the ARENA project protocol, published in the听(2024).

The ARENA project is funded by an Australian Government National Health and Medical Research Council (NHMRC) Investigator Grant.听 The ARENA project has ethics approval from The University of Sydney Human Research Ethics Committee (Project No. 2023/551) and the Australian Institute of Sport (AIS) Ethics Committee (approval number 20240601).

The ARENA project is a declared federal quality assurance activity under part VC of the Health Insurance Act 1973 (Cth). This legislative protection is known as 鈥渜ualified privilege鈥 and aims to encourage clinicians and organisations to participate in quality improvement activities. It:

  • prohibits disclosure of information or documents (even to a Court) created/known solely as a result of ARENA activities;
  • protects clinicians from civil liability as a result of participation in ARENA; and
  • protects confidentiality of athletes and clinicians involved.

Written consent is provided by sporting organisations. No written consent is required from individual athletes.

Data is collected from most sporting organisations as follows:

  • An initial collection of retrospective data (completed screenings) under a waiver of consent; and
  • Ongoing collection of prospective data (future screenings) using an opt-out consent process where athletes are informed about the registry during screening.

Athletes are able opt-out at any time if desired (see 鈥楶articipant materials鈥 for more details).

Data on athlete screening results will be collected directly from participating sporting organisations. The data will be deidentified and securely stored and athletes will听not听be identifiable in any publications.

Data will include some demographic information (including听name, sex, date of birth, sport/distance/event), together with the date and result of each cardiac screening, a copy of the ECG and any other cardiac tests/reports, whether follow-up tests were required and the outcome, any cardiac diagnosis, and any major adverse cardiac events.

The data collected will be re-identifiable. Once the information is entered into the Registry, it will be given a unique identification number which links to each athlete鈥檚 name and date of birth. This information allows ARENA to link multiple screenings to the same athlete, identify duplicates, add later outcome data (e.g. details of a cardiac diagnosis) or to communicate with the sporting organisation (e.g. if a previously unrecognised ECG abnormality is noticed by the Registry team or if the sport/athlete requests a copy of their own data).

Athletes can opt-out at any time if desired (see 鈥楶articipant materials鈥 for more details).

Our people

  • e (2025, Journal of the Heart Association)
  • (2024, Journal of the American Heart Association)
  • (2023, JSAMS)
  • Orchard Sports Injury and Illness Classification System (OSIICS) Version 15 (2024, J Sport Health Sci)
  • (2023, Indian J Orthop)
  • (2023, J Postgrad Med Edu Res)
  • (2023, Clin Cardiol)
  • (2022, J Electrocardiol)
  • (2022, J Cardiovasc Dev Dis)
  • (2022, Eur Heart J Case Rep)
  • Reduced death rates of elite Australian Rules footballers compared to age-matched general population (2022, JSAMS)
  • (2020, JSAMS)
  • (2019, Heart Rhythm)

2025 updates to International Criteria for Athlete ECG Interpretation

The International Criteria for Athlete ECG Interpretation (2017) are the current gold standard for athlete ECG interpretation. The International Criteria are the most accurate athlete-specific criteria to date, with a sensitivity of 86% and an improved specificity (97-99%). While this reduction in the false positive rate has been helpful, a number of common interpretation challenges and potential future directions have been suggested based on evolving science.

Accordingly, the International Criteria are in the process of being updated. The 3rd International Summit on ECG Interpretation in Athletes was held in Seattle, USA in 2025. The new criteria are expected to be published in 2026.

Our people

  • Associate Professor听, registry director chief investigator
  • Professor听Andre La Gerche, sports cardiologist and imaging specialist
  • Associate Professor听Hari Raju, cardiologist and electrophysiologist
  • Professor听, cardiologist and cMRI expert
  • Dr听Simon Eggleton, cardiologist and imaging expert
  • Mr Angus Davis, PhD candidate and cardiac nurse
  • Dr听Bruce Hamilton听(NZ), sports physician
  • Professor听Rob Doughty听(NZ), cardiologist
  • Professor听Jonathan Drezner听(USA), sports physician and registry expert
  • Professor听, sports physician
  • 听team including data managers, registry managers and biostatisticians
  • Consumer/athlete representatives
  • Representatives from participating sports, including the Australian Institute of Sport

Useful links

Engage with us

  • false
  • Partner with us false
  • Support us false
  • false